Reducing Cancer Risk Via Diet
Posted on: Wednesday, 9 April 2008, 12:00 CDT
A U.S. health group suggests a diet high in vegetables and fruits -- 10 servings a day -- helps reduce the risk of cancer.
The American Cancer Society says having at least five servings of fruits and vegetables a day has been recommended for a long time, but many experts are now advising at least doubling that amount.
The experts at the American Cancer Society say the role of diet in cancer is far from established, but the research does indicate a plant-based diet is associated with reduced risk for several cancers -- especially for colon cancer. To reduce colon and other cancer risks the American Cancer Society advises to:
-- Keep the intake of red meat to a minimum -- no more than 4 ounces of red meat per day on average and avoid processed meats such as sausage since the chemicals used to process them have been found to cause several kinds of cancer.
-- Help keep weight down by minimizing the intake of high-calorie foods such as sugar drinks, refined breads and potato chips.
-- Eat foods with high calcium and vitamin D levels such as fortified low- or non-fat milk and yogurt. Some may want to have their doctor check their blood level of vitamin D, because many Americans have been found to have a deficiency in this vitamin.
Source: United Press International
Related Articles
- BioVex to Report Phase I/II Clinical Trial Results for the Front Line Treatment of Head and Neck Cancer With OncoVEX GM-CSF at the 2009 American Society of Clinical Oncology Meeting
- Researchers Tapped Thomson Reuters Community of Cancer Patients for Studies To Be Reported at American Society of Clinical Oncology Conference
- Spectrum Pharmaceuticals to Present Phase 2 Data on Ortataxel in Breast Cancer at the American Society of Clinical Oncology (ASCO) Annual Meeting
- Abbott to Present Data on Novel Cancer Treatments at American Society of Clinical Oncology Annual Meeting
- MedImmune's Advancing Cancer Pipeline to Be Highlighted at the American Society of Hematology's Annual Meeting
- Amgen Oncology Highlights Upcoming Data Presentations at the American Society of Clinical Oncology Annual Meeting; Clinical Data to Be Presented on Four Investigational Targeted Cancer Therapies
- Data From Tarceva-TM- Clinical Trial Program Presented at American Society of Clinical Oncology Annual Meeting; EGFR Amplification / Mutation Analysis From the Registration BR.21 Trial Presented
- New Eloxatin(R) and Taxotere(R) Research to Be Presented at the Annual Meeting of the American Society of Clinical Oncology (ASCO)
- Abbott to Present New Data on Its Oncology Pipeline at the American Society of Clinical Oncology (ASCO) Annual Meeting
- American Society of Breast Surgeons Meeting Being Held in Los Angeles, March 16-20; Largest Assembly of Breast Cancer Experts to Share Cutting-Edge Research
 |
 |
User Comments (0)
RSS Feeds